Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2022 By: Benzinga via Benzinga March 07, 2022 at 10:03 AM EST Upgrades According to Brookline Capital, the prior rating for Intellia Therapeutics Inc (NASDAQ:NTLA) was changed from Hold to Buy. In ... Read More >> Related Stocks: AT&T Inc American Airlines Gp Anglogold Ashanti Ltd ADR Augmedix Inc Azul S.A. ADR BRCC Ball Corp Bank of Montreal Biotricity Inc Bluebird Bio Carter's Inc Chindata Group Holdings Ltd ADR Citigroup Coherus Bio Draftkings Inc Empire State Realty Trust Inc First Horizon Corp Five Below Inc Gol Linhas Aereas Inteligentes S.A. ADR Intellia Thera CS Lloyds Banking Group Plc ADR Microvision Mosaic Co NextEra Energy Nutrien Ltd Oil States International PVH Corp Palantir Technologies Inc Cl A Philip Morris International Portage Biotech Inc Ord Ralph Lauren Corp SGHC Sempra Energy Sofi Technologies Inc Store Capital Corp Tal Education Group ADR Toronto-Dominion Bank Ugi Corp United States Steel Corp Youdao Inc ADR